Compound Detail
CHEMBL1770257
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL1770257 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | BHHSURXPIUIOSV-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
3
PK Parameters
4
Publications
0
Known Names
Molecular Properties
475.6
MW (Da)
6.29
ALogP
6
HBA
1
HBD
89.6
PSA (Ų)
0.15
QED
1
Ro5 Violations
12
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 6.85
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 6.85 | 6.145 | 140.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 35.0 | uL/min | Rattus norvegicus |
| CL | 200.0 | mL.min-1.kg-1 | Rattus norvegicus |
| T1/2 | 0.2 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 140.0 | nM | 6.85 | Inhibition of recombinant cytosolic PLA2alpha assessed as inhibition of cleavage... | 21450464 |
| Unchecked | IC50 | = | 3600.0 | nM | 5.44 | Inhibition of cytosolic PLA2alpha in human differentiated HL60 cells assessed as... | 21450464 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 21450464 | 10.1016/j.bmcl.2011.03.005 | Rattus norvegicus | 3 |
| 21450464 | 10.1016/j.bmcl.2011.03.005 | Unchecked | 2 |
| 21450464 | 10.1016/j.bmcl.2011.03.005 | Liver | 1 |
| 21450464 | 10.1016/j.bmcl.2011.03.005 | Hepatocyte | 1 |
Data from ChEMBL 36 via Core Engine